Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Highlights Nominees’ Robust Skillsets and Extensive Experience in Healthcare and Biopharmaceuticals Urges Stockholders to Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE...
-
New York, USA, May 12, 2026 (GLOBE NEWSWIRE) -- Sepsis Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The sepsis...
-
Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Healthcare Analytics Market" report has been added to ResearchAndMarkets.com's offering. In 2024, the market is valued at approximately USD 50.01...
-
Escalent’s latest Fleet Advisory Hub™ research report uncovers a clear disconnect in expected outcomes and lived experiences of telematics adopters.
-
LOS ANGELES, May 12, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gartner, Inc., (“Gartner” or the “Company”) (NYSE:IT) investors off a class action on behalf of investors that bought...
-
EDEN PRAIRIE, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Arctic Wolf®, the cybersecurity and AI company, today announced Aurora® Exposure Management, a new family of products designed to help...
-
ARLINGTON, Va., May 12, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a global market leader delivering intelligent energy storage, operational services, and asset...
-
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
-
MELBOURNE, Australia and NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for...
-
Second Positive DSMB Review Supports Continued Study Progress Interim Phase 3 Results Support Ovaprene’s Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly Contraceptive SAN...